# Efficacy Study of Ilaprazole to Treat Erosive Esophgitis

> **NCT01509261** · PHASE3 · COMPLETED · sponsor: **Il-Yang Pharm. Co., Ltd.** · enrollment: 292 (actual)

## Conditions studied

- Erosive Esophagitis
- GERD

## Interventions

- **DRUG:** Ilaprazole
- **DRUG:** Lansoprazole

## Key facts

- **NCT ID:** NCT01509261
- **Lead sponsor:** Il-Yang Pharm. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 292 (ACTUAL)
- **Last updated:** 2012-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01509261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01509261, "Efficacy Study of Ilaprazole to Treat Erosive Esophgitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01509261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*